Total item
Cart Subtotal
$0.00 Biological Activity
Evacetrapib (LY2484595) is a potent and selective inhibitor of CETP with IC50 of 5.5 nM, elevates HDL cholesterol without increases in aldosterone or blood pressure. Phase 3.
Targets
| CETP | ||||
| 5.5 nM |
| In vitro (25°C) | DMSO | 11 mg/mL (17.22 mM) | |
| Water | Insoluble | ||
| Ethanol | 11 mg/mL (17.22 mM) | ||
| In vivo | 15% Captisol | 28 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 15.66 mL | 78.29 mL | 156.58 mL |
| 0.5 mM | 3.13 mL | 15.66 mL | 31.32 mL |
| 1 mM | 1.57 mL | 7.83 mL | 15.66 mL |
| 5 mM | 0.31 mL | 1.57 mL | 3.13 mL |
*The above data is based on the productmolecular weight 638.65. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A11397 |
|---|---|
| Actions | Inhibitor |
| CAS No. | 1186486-62-3 |
| Formula | C31H36F6N6O2 |
| M. Wt | 638.65 |
| Purity | >98% |
| Synonyms | LY2484595, LY-2484595, LY 2484595 |
| SMILES | CC1=CC(=C2C(=C1)[[email protected]](CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy Evacetrapib (LY2484595) | Evacetrapib (LY2484595) Supplier | purchase | cost | manufacturer | order | distributor | buy 1186486-62-3| 1186486-62-3 Supplier | purchase 1186486-62-3 | 1186486-62-3 cost | 1186486-62-3 manufacturer | order 1186486-62-3 | 1186486-62-3 distributor
Adooq Quality Guarantee
We promise all products perform as described.